Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NUC-7738 |
Trade Name | |
Synonyms | NUC7738|NUC 7738 |
Drug Descriptions |
NUC-7738 is a prodrug of 3’-deoxyadenosine, which potentially decreases beta-catenin signaling and tumor cell proliferation and increases tumor cell apoptosis (PMID: 36520954, PMID: 36417756). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C171381 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NUC-7738 | NUC-7738 | 0 | 1 |
NUC-7738 + Pembrolizumab | NUC-7738 Pembrolizumab | 0 | 1 |